NAD precursors raise blood NAD levels, but trials haven't shown a cognitive benefit yet.

If you've seen NMN or NR bottles on the shelf, you might be looking for a way to recharge your cellular batteries and protect your mind from the slow, structural decline of aging ¹. The logic is straightforward. If you can elevate your levels of NAD+, a key molecule for energy and repair, you might bolster your brain's defenses ². But when we look closely at the human clinical trials, the link between higher NAD+ and a sharper, more resilient mind remains unproven.

The evidence that these precursors actually raise NAD+ is strong. In a double-blind, multicenter trial of 80 healthy adults aged 40 to 65, researchers found that oral NMN doses of 300 mg, 600 mg, and 900 mg per day all significantly increased blood NAD concentrations ¹. This wasn't just a temporary spike; the increases were sustained at both 30 and 60 days when compared to both the starting baseline and the placebo group ¹. While all doses worked, the highest NAD concentrations were found in the 600 mg and 900 mg daily dose groups, suggesting that the benefits might scale with the amount taken ¹.

This metabolic surge also appeared to benefit the body in other ways. Participants taking NMN saw significant improvements in their six-minute walking distance compared to the placebo group ². They also reported better general health and quality of life, as measured by the SF-36 scale (a standard health survey) ². There was, however, one notable absence: NMN didn't appear to change HOMA-IR, a common measure of insulin resistance, meaning the metabolic benefit might be more specific to certain pathways rather than a broad metabolic overhaul ².

But the jump from better physical performance to better mental performance hasn't happened yet. In a trial involving 20 older adults with mild cognitive impairment (MCI), researchers found that NR could reliably push NAD+ levels higher ³. After a 10-week course of 1 g/day NR, participants saw a 2.6-fold increase in blood NAD+ ³. It was a significant biological shift. Yet, despite this change in the blood, their scores on the Montreal Cognitive Assessment (MoCA), a standard tool for measuring cognitive function, remained stable ⁴. The brain's performance essentially ignored the chemistry.

Recent findings have added even more layers to this complexity. A crossover study in older adults with subjective cognitive decline or MCI found that NR did not improve performance on common cognitive tests like the RBANS (a standard neuropsychological test battery) or Lumosity (a cognitive-training app) ⁵. However, researchers did find a flicker of a different kind of signal. In the NR group, plasma pTau217, a specific protein residue that frequently appears in the blood of people developing Alzheimer's disease, was 7% lower than in the placebo group, which actually saw an 18% increase in the protein ⁵. This was a single, modest signal in a small group. While it is a potential biomarker for disease, it does not mean these supplements are currently providing clinical cognitive protection ⁵.

The current evidence base is also limited by how and where the studies are conducted. Many of the primary trials have been small and focused on very specific populations, such as adults in South Asia or South Texas ¹³⁵. This makes it difficult to know if the results we see in one group will hold true for everyone. We also face a major question about measurement. Different studies use different methods to measure NAD+, from colorimetric assays to more precise LC-MS/MS techniques, and these different approaches can lead to vastly different reported results ¹.

Furthermore, we still don't know how much is enough. While NMN seems to work effectively at 600 mg or 900 mg for raising blood NAD, we lack a clear dose-response curve that tells us how different amounts might affect the brain specifically ¹. We are also seeing a stark asymmetry in the research itself. While there is a growing interest in using NR to address cognitive health, there is almost no record of human clinical trials using NMN specifically as a therapeutic intervention for Alzheimer's disease ⁶.

We can see a hint of what might be possible in the laboratory, but these findings are still far from certain. In mice, NMN has been shown to protect against certain types of neurodegeneration by activating a cellular pathway known as Sirt1 ⁷. This research also suggested that NMN might help protect the intestinal barrier in these animal models ⁷. But these are mechanistic studies in rodents; they do not prove that the same process will occur in a human brain, especially as the mouse models used often involve accelerated aging that doesn't perfectly mimic the human experience ⁷.

For now, the story of NAD+ precursors is one of disconnected signals. We have clear evidence that they can raise NAD+ levels in human blood, and we know they are generally safe at the doses tested ²³. But the leap from higher NAD+ to a more resilient mind is a gap that science has yet to bridge. If you are considering adding these to your routine, talk to your doctor first, especially if you have an existing medical condition or take other medications. Perhaps keep an eye on those white bottles sitting on your bathroom counter, but know that the chemistry in your blood hasn't yet translated to the clarity in your mind.